| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Ophthalmology and Visual Sciences, the Chinese University of Hong Kong.
PURPOSE. To investigate the coding exons in the trabecular meshwork–induced glucocorticoid response protein (TIGR) gene for mutations in primary open-angle glaucoma (POAG) in Chinese subjects.
METHODS. Ninety-one Chinese patients with POAG and 113 of their family members without glaucoma were screened for sequence alterations in the TIGR gene by polymerase chain reaction, conformation-sensitive gel electrophoresis, and DNA sequencing. One hundred thirty-two unrelated individuals without glaucoma, aged 50 years or more, were studied as control subjects.
RESULTS. Five sequence variants that lead to amino acid changes were identified.
One was novel: Arg91Stop in one patient with POAG. Four had been
reported: Arg46Stop in subjects with and without POAG, including an
unaffected 77-year-old woman homozygous for Arg46Stop; Gly12Arg in
subjects without glaucoma; and Asp208Glu and Thr353Ile in subjects with
and without POAG. The previously reported 1-83(G
A) and Arg76Lys
polymorphisms were detected in both patients and controls and always
occurred together.
CONCLUSIONS. A different pattern of TIGR sequence variants exists in the Chinese than in non-Chinese populations. No common TIGR mutation that causes POAG was found. The occurrence of subjects without glaucoma who are heterozygous or homozygous for Arg46Stop suggests that reduction in the amount of TIGR protein does not cause glaucoma. Thus, the TIGR missense mutations known to cause POAG probably do not cause glaucoma by inactivating a normal TIGR function, but rather through the gain of a pathologic function.
This article has been cited by other articles:
|
|
 |
|
  H.-S. Kwon, H.-S. Lee, Y. Ji, J. S. Rubin, and S. I. Tomarev Myocilin Is a Modulator of Wnt Signaling Mol. Cell. Biol., April 15, 2009; 29(8): 2139 - 2154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. H. Kwon, J. H. Fingert, M. H. Kuehn, and W. L.M. Alward Primary Open-Angle Glaucoma N. Engl. J. Med., March 12, 2009; 360(11): 1113 - 1124. [Full Text] [PDF]
|
|
|
|
 |
|
 F. W. Rozsa, K. Scott, H. Pawar, S. Moroi, and J. E. Richards Effects of Timolol on MYOC, OPTN, and WDR36 RNA Levels Arch Ophthalmol, January 1, 2008; 126(1): 86 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bhattacharjee, M. Acharya, A. Mukhopadhyay, S. Mookherjee, D. Banerjee, A. K. Bandopadhyay, S. K. D. Thakur, A. Sen, and K. Ray Myocilin Variants in Indian Patients With Open-angle Glaucoma Arch Ophthalmol, June 1, 2007; 125(6): 823 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H.-F. Yam, K. Gaplovska-Kysela, C. Zuber, and J. Roth Sodium 4-Phenylbutyrate Acts as a Chemical Chaperone on Misfolded Myocilin to Rescue Cells from Endoplasmic Reticulum Stress and Apoptosis Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1683 - 1690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Shepard, N. Jacobson, J. C. Millar, I.-H. Pang, H. T. Steely, C. C. Searby, V. C. Sheffield, E. M. Stone, and A. F. Clark Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure Hum. Mol. Genet., March 15, 2007; 16(6): 609 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Wiggs Genetic Etiologies of Glaucoma Arch Ophthalmol, January 1, 2007; 125(1): 30 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H.-F. Yam, K. Gaplovska-Kysela, C. Zuber, and J. Roth Aggregated Myocilin Induces Russell Bodies and Causes Apoptosis: Implications for the Pathogenesis of Myocilin-Caused Primary Open-Angle Glaucoma Am. J. Pathol., January 1, 2007; 170(1): 100 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Y. Wang, B. J. Fan, J. K. H. Chua, P. O. S. Tam, C. K. S. Leung, D. S. C. Lam, and C. P. Pang A Genome-wide Scan Maps a Novel Juvenile-Onset Primary Open-Angle Glaucoma Locus to 15q Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5315 - 5321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Funayama, Y. Mashima, Y. Ohtake, K. Ishikawa, N. Fuse, N. Yasuda, T. Fukuchi, A. Murakami, Y. Hotta, N. Shimada, et al. SNPs and Interaction Analyses of Noelin 2, Myocilin, and Optineurin Genes in Japanese Patients with Open-Angle Glaucoma Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5368 - 5375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Gould, M. Reedy, L. A. Wilson, R. S. Smith, R. L. Johnson, and S. W. M. John Mutant Myocilin Nonsecretion In Vivo Is Not Sufficient To Cause Glaucoma Mol. Cell. Biol., November 15, 2006; 26(22): 8427 - 8436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Malyukova, H.-S. Lee, R. N. Fariss, and S. I. Tomarev Mutated Mouse and Human Myocilins Have Similar Properties and Do Not Block General Secretory Pathway Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 206 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Fan, D. Y. L. Leung, D. Y. Wang, S. Gobeil, V. Raymond, P. O. S. Tam, D. S. C. Lam, and C. P. Pang Novel Myocilin Mutation in a Chinese Family With Juvenile-Onset Open-Angle Glaucoma Arch Ophthalmol, January 1, 2006; 124(1): 102 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. M. John Mechanistic Insights into Glaucoma Provided by Experimental Genetics The Cogan Lecture Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2650 - 2661. [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Aroca-Aguilar, F. Sanchez-Sanchez, S. Ghosh, M. Coca-Prados, and J. Escribano Myocilin Mutations Causing Glaucoma Inhibit the Intracellular Endoproteolytic Cleavage of Myocilin between Amino Acids Arg226 and Ile227 J. Biol. Chem., June 3, 2005; 280(22): 21043 - 21051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Aung, V. H. K. Yong, P. T. K. Chew, S. K. L. Seah, G. Gazzard, P. J. Foster, and E. N. Vithana Molecular Analysis of the Myocilin Gene in Chinese Subjects with Chronic Primary-Angle Closure Glaucoma Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1303 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Gould, L. Miceli-Libby, O. V. Savinova, M. Torrado, S. I. Tomarev, R. S. Smith, and S. W. M. John Genetically Increasing Myoc Expression Supports a Necessary Pathologic Role of Abnormal Proteins in Glaucoma Mol. Cell. Biol., October 15, 2004; 24(20): 9019 - 9025. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gobeil, M.-A. Rodrigue, S. Moisan, T. D. Nguyen, J. R. Polansky, J. Morissette, and V. Raymond Intracellular Sequestration of Hetero-oligomers Formed by Wild-Type and Glaucoma-Causing Myocilin Mutants Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3560 - 3567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Melki, E Colomb, N Lefort, A P Brezin, and H-J Garchon CYP1B1 mutations in French patients with early-onset primary open-angle glaucoma J. Med. Genet., September 1, 2004; 41(9): 647 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu and D. Vollrath Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma Hum. Mol. Genet., June 1, 2004; 13(11): 1193 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Gong, O. Kosoko-Lasaki, G. R. Haynatzki, and M. R. Wilson Genetic dissection of myocilin glaucoma Hum. Mol. Genet., April 1, 2004; 13(90001): R91 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. P. Fan, C. B. O. Yu, T. Y. H. Chiu, C. Y. Wong, J. S. K. Ng, C. P. Pang, and D. S. C. Lam Ocular-Hypertensive and Anti-inflammatory Response to Rimexolone Therapy in Children Arch Ophthalmol, December 1, 2003; 121(12): 1716 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. F. Leung, B. J. Fan, D. S. C. Lam, W. S. Lee, P. O. S. Tam, J. K. H. Chua, C. C. Y. Tham, J. S. M. Lai, D. S. P. Fan, and C. P. Pang Different Optineurin Mutation Pattern in Primary Open-Angle Glaucoma Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 3880 - 3884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sohn, W. Hur, M. K. Joe, J.-H. Kim, Z.-W. Lee, K.-S. Ha, and C. Kee Expression of Wild-Type and Truncated Myocilins in Trabecular Meshwork Cells: Their Subcellular Localizations and Cytotoxicities Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3680 - 3685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Pang, Y. F. Leung, B. Fan, L. Baum, W. C. Tong, W. S. Lee, J. K. H. Chua, D. S. P. Fan, Y. Liu, and D. S. C. Lam TIGR/MYOC Gene Sequence Alterations in Individuals with and without Primary Open-Angle Glaucoma Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3231 - 3235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Torrado, R. Trivedi, R. Zinovieva, I. Karavanova, and S. I. Tomarev Optimedin: a novel olfactomedin-related protein that interacts with myocilin Hum. Mol. Genet., May 16, 2002; 11(11): 1291 - 1301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ahmed, M. Torrado, E. Johnson, J. Morrison, and S. I. Tomarev Changes in mRNA Levels of the Myoc/Tigr Gene in the Rat Eye after Experimental Elevation of Intraocular Pressure or Optic Nerve Transection Invest. Ophthalmol. Vis. Sci., December 1, 2001; 42(13): 3165 - 3172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Kim, O. V. Savinova, M. V. Reedy, J. Martin, Y. Lun, L. Gan, R. S. Smith, S. I. Tomarev, S. W. M. John, and R. L. Johnson Targeted Disruption of the Myocilin Gene (Myoc) Suggests that Human Glaucoma-Causing Mutations Are Gain of Function Mol. Cell. Biol., November 15, 2001; 21(22): 7707 - 7713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Wiggs and D. Vollrath Molecular and Clinical Evaluation of a Patient Hemizygous for TIGR/MYOC Arch Ophthalmol, November 1, 2001; 119(11): 1674 - 1678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Jacobson, M. Andrews, A. R. Shepard, D. Nishimura, C. Searby, J. H. Fingert, G. Hageman, R. Mullins, B. L. Davidson, Y. H. Kwon, et al. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor Hum. Mol. Genet., January 1, 2001; 10(2): 117 - 125. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
